health care
-
'Lives at risk': why is the NHS suffering drug shortages?
Today's Big Question Brexit exacerbates global supply issues caused by Covid-19, Ukraine war and Red Sea attacks
By Harriet Marsden, The Week UK Published
Today's Big Question -
How a new blood test could revolutionise sepsis diagnosis
The Explainer Early results from ongoing trial suggest faster identification of deadly condition is possible
By The Week Staff Published
The Explainer -
Nothing to smile about: the sudden demise of Smile Direct Club
Under the radar Customers left 'adrift' after controversial teeth-straightening company announces immediate closure
By Arion McNicoll, The Week UK Published
Under the radar -
Babylon Health: the failed AI wonder app that 'dazzled' politicians
The Explainer Demise of UK tech start-up is a cautionary tale for politicians seeking quick fixes to complicated problems
By The Week UK Last updated
The Explainer -
Ageing boomers: America’s looming crisis
Under the radar A person turning 65 today in US has an almost 70% chance of needing long-term care
By The Week Staff Published
Under the radar -
Anastrozole: the daily breast cancer pill tipped to save thousands of lives
The Explainer Existing treatment approved for preventative use under 'pioneering' NHS drug repurposing scheme
By Harriet Marsden, The Week UK Published
The Explainer -
The pros and cons of safe injection sites for opioids
Pros and cons The sites have saved lives but many worry they're too lax
By Devika Rao, The Week US Published
Pros and cons -
The pros and cons of human genetic modification
Pros and Cons Altering human DNA has both a lot of potential and a lot of ethical questions
By Devika Rao, The Week US Published
Pros and Cons -
How viruses can help fight antibiotic-resistant infections
Speed Read So-called phage therapy could be the next big thing
By Devika Rao, The Week US Published
Speed Read -
Experts are worried about tuberculosis again
Speed Read The deadly disease regained its crown as the world's biggest infectious killer in October 2022
By Devika Rao, The Week US Published
Speed Read -
Will Medicare drug price controls save lives?
Talking Point Medicare starts negotiating lower drug prices over Big Pharma protests
By Harold Maass Published
Talking Point -
What are longevity clinics?
Speed Read Meeting the growing demand to stay young
By Devika Rao Published
Speed Read -
The big changes coming to HSAs in 2024
feature We're about to see the 'largest ever increase' to annual health savings accounts contributions
By Becca Stanek, The Week US Published
feature -
Do pharmacies have too much power?
Speed Read Pharmacists can legally deny prescriptions. Is this a problem?
By Devika Rao, The Week US Published
Speed Read